Washington University in St. Louis at CTAD 2026
Nov 16–19, 2026 Boston, MA ~1.7k attendees Website
Washington University in St. Louis takes part in 15 sessions at CTAD 2026 in Boston. Its program centres on blood and CSF biomarkers, from plasma tau isomerization to p-tau217 risk estimates, together with trial design. Its work also covers tau PET in autosomal dominant Alzheimer's disease and agentic AI for clinical trial design.
| Organization | CTAD 2026 Attendance |
|---|---|
Washington University in St. Louis St. Louis, Missouri | |
Leads the DIAN network and DIAN-TU trials in inherited Alzheimer's disease, and runs the Knight Alzheimer Disease Research Center. | Poster Mon Nov 16 – Tue Nov 17 2:00pm Mon – 5:30pm Tue Poster Mon Nov 16 – Tue Nov 17 2:00pm Mon – 5:30pm Tue Poster Mon Nov 16 – Tue Nov 17 2:00pm Mon – 5:30pm Tue Session Mon Nov 16 4:50pm–5:30pm Talk Mon Nov 16 5:30pm Talk Tue Nov 17 3:30pm Poster Wed Nov 18 7:15am–5:30pm Talk Wed Nov 18 9:15am Talk Wed Nov 18 4:45pm Poster Thu Nov 19 7:15am–5:00pm Poster Thu Nov 19 7:15am–5:00pm Poster Thu Nov 19 7:15am–5:00pm Poster Thu Nov 19 7:15am–5:00pm |
Instantly find 20 buyers from Washington University in St. Louis
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the CTAD Conference. Organization details are derived from CTAD’s published program, poster list and sponsor page. Submit a correction